Novel Neoadjuvant and Adjuvant Strategy for Germline BRCA 1/2 Mutated Triple Negative Breast Cancer
Okayama University
Okayama University
OHSU Knight Cancer Institute
OHSU Knight Cancer Institute
Roswell Park Cancer Institute
The Netherlands Cancer Institute
Children's Oncology Group
M.D. Anderson Cancer Center
Amgen
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center
AGO Study Group